Global Colorectal Surgical Devices Market - Industry Trends and Forecast to 2029

TABLE OF CONTENT

TABLE OF CONTENTS
1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.3 OVERVIEW OF GLOBAL COLORECTAL SURGICAL DEVICES MARKET 25
1.4 LIMITATIONS 26
1.5 MARKETS COVERED 26
2 MARKET SEGMENTATION 28
2.1 MARKETS COVERED 28
2.2 GEOGRAPHICAL SCOPE 29
2.3 YEARS CONSIDERED FOR THE STUDY 30
2.4 CURRENCY AND PRICING 30
2.5 DBMR TRIPOD DATA VALIDATION MODEL 31
2.6 MULTIVARIATE MODELLING 34
2.7 PRODUCT TYPE LIFELINE CURVE 34
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
2.9 DBMR MARKET POSITION GRID 36
2.10 MARKET APPLICATION COVERAGE GRID 37
2.11 VENDOR SHARE ANALYSIS 38
2.12 SECONDARY SOURCES 39
2.13 ASSUMPTIONS 39
3 EXECUTIVE SUMMARY 40
4 PREMIUM INSIGHTS 43
4.1 PESTEL ANALYSIS 44
4.2 PORTERS FIVE FORCES 45
5 INDUSTRIAL INSIGHTS: 46
CONCLUSION: 46
6 GLOBAL COLORECTAL SURGICAL DEVICES MARKET: REGULATIONS 47
6.1 REGULATION IN U.S 47
6.2 REGULATION IN EUROPE 48
6.3 REGULATION IN CANADA 48
6.4 REGULATION IN SOUTH AFRICA 49

7 MARKET OVERVIEW 50
7.1 DRIVERS 52
7.1.1 INCREASE IN GERIATRIC POPULATION 52
7.1.2 RISE IN NUMBER OF PATIENTS SUFFERING FROM DIVERTICULITIS AND ULCERATIVE COLITIS 52
7.1.3 INCREASE IN HEALTHCARE EXPENDITURE 53
7.1.4 RISE IN PREVALENCE OF COLORECTAL CANCER 54
7.2 RESTRAINTS 55
7.2.1 HIGH COST OF COLORECTAL SURGERY DEVICES 55
7.2.2 STRICT REGULATIONS 55
7.3 OPPORTUNITIES 56
7.3.1 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS AND GOVERNMENT 56
7.3.2 INCREASE IN MINIMAL INVASIVE SURGERY PROCEDURE 56
7.3.3 RISING DISPOSABLE INCOME 57
7.4 CHALLENGES 57
7.4.1 COMPLICATIONS ASSOCIATED WITH PROCEDURE 57
1.4.1 SHORTAGE OF SKILLED PERSONNEL 58
8 GLOBAL COLORECTAL SURGICAL DEVICES MARKET, BY PRODUCT TYPE 59
8.1 OVERVIEW 60
8.2 ENDOSCOPE 63
8.2.1 LAPAROSCOPE 64
8.2.2 COLONSCOPE 64
8.3 ELECTROSURGERY 64
8.3.1 INSTRUMENTS 65
8.3.2 ACCESSORIES 65
8.4 HANDHELD INSTRUMENTS 65
8.4.1 SCISSORS 66
8.4.2 FORCEPS 66
8.4.3 OTHERS 66
8.5 SEALING DEVICES 67
8.6 SURGICAL STAPLING DEVICES 68
8.7 ACCESSORIES 69
9 GLOBAL COLORECTAL SURGICAL DEVICES MARKET, BY INDICATION 70
9.1 OVERVIEW 71
9.2 COLORECTAL CANCER 74
9.3 DIVERTICULITIS 75
9.4 ULCERATIVE COLITIS 76
9.5 CROHN'S DISEASE 77
9.6 OTHERS 78
10 GLOBAL COLORECTAL SURGICAL DEVICES MARKET, BY END USER 79
10.1 OVERVIEW 80
10.2 SURGICAL CENTERS 83
10.3 HOSPITALS 84
10.4 CLINICS 85
10.5 OTHERS 86
11 GLOBAL COLORECTAL SURGICAL DEVICES MARKET, BY REGION 87
11.1 OVERVIEW 88
11.2 NORTH AMERICA 93
11.2.1 U.S. 99
11.2.2 CANADA 101
11.2.3 MEXICO 103
11.3 EUROPE 105
11.3.1 GERMANY 111
11.3.2 FRANCE 113
11.3.3 U.K. 115
11.3.4 ITALY 117
11.3.5 SPAIN 119
11.3.6 TURKEY 121
11.3.7 RUSSIA 123
11.3.8 NETHERLANDS 125
11.3.9 SWITZERLAND 127
11.3.10 BELGIUM 129
11.3.11 REST OF EUROPE 131
11.4 ASIA-PACIFIC 132
11.4.1 CHINA 138
11.4.2 JAPAN 140
11.4.3 SOUTH KOREA 142
11.4.4 INDIA 144
11.4.5 AUSTRALIA 146
11.4.6 SINGAPORE 148
11.4.7 THAILAND 150
11.4.8 MALAYSIA 152
11.4.9 INDONESIA 154
11.4.10 PHILIPPINES 156
11.4.11 REST OF ASIA-PACIFIC 158

11.5 SOUTH AMERICA 159
11.5.1 BRAZIL 165
11.5.2 ARGENTINA 167
11.5.3 REST OF SOUTH AMERICA 169
11.6 MIDDLE EAST AND AFRICA 170
11.6.1 SOUTH AFRICA 176
11.6.2 SAUDI ARABIA 178
11.6.3 U.A.E. 180
11.6.4 ISRAEL 182
11.6.5 EGYPT 184
11.6.6 REST OF MIDDLE EAST AND AFRICA 186
12 GLOBAL COLORECTAL SURGICAL DEVICES MARKET: COMPANY LANDSCAPE 187
12.1 COMPANY SHARE ANALYSIS: GLOBAL 187
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 188
12.3 COMPANY SHARE ANALYSIS: EUROPE 189
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 190
13 COMPANY PROFILE 191
13.1 MEDTRONIC 191
13.1.1 COMPANY SNAPSHOT 191
13.1.2 REVENUE ANALYSIS 192
13.1.3 COMPANY SHARE ANALYSIS 192
13.1.4 PRODUCT PORTFOLIO 192
13.1.5 RECENT DEVELOPMENT 193
13.1.5.1 PRODUCT LAUNCH 193
13.2 STRYKER 194
13.2.1 COMPANY SNAPSHOT 194
13.2.2 REVENUE ANALYSIS 194
13.2.3 COMPANY SHARE ANALYSIS 195
13.2.4 PRODUCT PORTFOLIO 195
13.2.5 RECENT DEVELOPMENTS 196
13.2.5.1 ACQUISITION 196
13.3 JOHNSON & JOHNSON SERVICES, INC 197
13.3.1 COMPANY SNAPSHOT 197
13.3.2 REVENUE ANALYSIS 197
13.3.3 COMPANY SHARE ANALYSIS 198
13.3.4 PRODUCT PORTFOLIO 198
13.3.5 RECENT DEVELOPMENTS 198
13.3.5.1 FDA CLEARANCE 198
13.3.5.2 STUDY RESULTS 198
13.4 BOSTON SCIENTIFIC CORPORATION 200
13.4.1 COMPANY SNAPSHOT 200
13.4.2 REVENUE ANALYSIS 200
13.4.3 COMPANY SHARE ANALYSIS 201
13.4.4 PRODUCT PORTFOLIO 201
13.4.5 RECENT DEVELOPMENTS 201
13.4.5.1 PRODUCT LAUNCH 201
13.4.5.2 AGREEMENT 202
13.5 KARL STORZ SE & CO. KG 203
13.5.1 COMPANY SNAPSHOT 203
13.5.2 COMPANY SHARE ANALYSIS 203
13.5.3 PRODUCT PORTFOLIO 204
13.5.4 RECENT DEVELOPMENTS 204
13.5.4.1 CONTRACT 204
13.5.4.2 INVESTMENT 205
13.6 BD 206
13.6.1 COMPANY SNAPSHOT 206
13.6.2 REVENUE ANALYSIS 206
13.6.3 PRODUCT PORTFOLIO 207
13.6.4 RECENT DEVELOPMENT 207
13.6.4.1 ACQUISITION 207
13.7 BIPAD SURGICAL, INC 208
13.7.1 COMPANY SNAPSHOT 208
13.7.2 PRODUCT PORTFOLIO 208
13.7.3 RECENT DEVELOPMENT 208
13.7.3.1 FDA APPROVAL 208
13.8 CARDINAL HEALTH 209
13.8.1 COMPANY SNAPSHOT 209
13.8.2 REVENUE ANALYSIS 209
13.8.3 PRODUCT PORTFOLIO 210
13.8.4 RECENT DEVELOPMENTS 210
13.8.4.1 NEW DISTRIBUTION CENTER 210
13.8.4.2 NEW DISTRIBUTION CENTER 210
13.9 COOK GROUP 211
13.9.1 COMPANY SNAPSHOT 211
13.9.2 PRODUCT PORTFOLIO 211
13.9.3 RECENT DEVELOPMENTS 212
13.9.3.1 ISO CERTIFICATION 212
13.9.3.2 INVESTMENT 212

13.10 CONMED CORPORATION 213
13.10.1 COMPANY SNAPSHOT 213
13.10.2 REVENUE ANALYSIS 213
13.10.3 PRODUCT PORTFOLIO 214
13.10.4 RECENT DEVELOPMENT 214
13.10.4.1 CONFERENCE 214
13.11 HALLMARK SURGICAL 215
13.11.1 COMPANY SNAPSHOT 215
13.11.2 PRODUCT PORTFOLIO 215
13.11.3 RECENT DEVELOPMENT 215
13.12 HEBSON 216
13.12.1 COMPANY SNAPSHOT 216
13.12.2 PRODUCT PORTFOLIO 216
13.12.3 RECENT DEVELOPMENT 216
13.13 OLYMPUS CORPORATION 217
13.13.1 COMPANY SNAPSHOT 217
13.13.2 REVENUE ANALYSIS 217
13.13.3 PRODUCT PORTFOLIO 218
13.13.4 RECENT DEVELOPMENT 218
13.13.4.1 PRODUCT LAUNCH 218
13.14 OVESCO ENDOSCOPY AG 219
13.14.1 COMPANY SNAPSHOT 219
13.14.2 PRODUCT PORTFOLIO 219
13.14.3 RECENT DEVELOPMENT 219
13.14.3.1 MARKET APPROVAL 219
13.15 PENTAX MEDICAL 220
13.15.1 COMPANY SNAPSHOT 220
13.15.2 REVENUE ANALYSIS 220
13.15.3 PRODUCT PORTFOLIO 221
13.15.4 RECENT DEVELOPMENTS 221
13.15.4.1 JOINT VENTURE 221
13.16 RICHARD WOLF GMBH 222
13.16.1 COMPANY SNAPSHOT 222
13.16.2 PRODUCT PORTFOLIO 222
13.16.3 RECENT DEVELOPMENT 222
13.16.3.1 NEW SUBSIDIARY 222

13.17 SAFEHEAL 223
13.17.1 COMPANY SNAPSHOT 223
13.17.2 PRODUCT PORTFOLIO 223
13.17.3 RECENT DEVELOPMENT 223
13.17.3.1 PARTNERSHIP 223
13.18 SMITH + NEPHEW 224
13.18.1 COMPANY SNAPSHOT 224
13.18.2 REVENUE ANALYSIS 224
13.18.3 PRODUCT PORTFOLIO 225
13.18.4 RECENT DEVELOPMENT 225
13.18.4.1 FDA APPROVAL 225
13.19 SUMMIT HILL LABORATORIES 226
13.19.1 COMPANY SNAPSHOT 226
13.19.2 PRODUCT PORTFOLIO 226
13.19.3 RECENT DEVELOPMENT 226
13.20 SYMMETRY SURGICAL, INC 227
13.20.1 COMPANY SNAPSHOT 227
13.20.2 PRODUCT PORTFOLIO 227
13.20.3 RECENT DEVELOPMENTS 228
13.20.3.1 ACQUISITION 228
13.21 TELEFLEX INCORPORATED 229
13.21.1 COMPANY SNAPSHOT 229
13.21.2 REVENUE ANALYSIS 229
13.21.3 PRODUCT PORTFOLIO 230
13.21.4 RECENT DEVELOPMENT 230
13.21.4.1 CONFERENCE 230
13.22 THE COOPER COMPANIES INC. 231
13.22.1 COMPANY SNAPSHOT 231
13.22.2 REVENUE ANALYSIS 231
13.22.3 PRODUCT PORTFOLIO 232
13.22.4 RECENT DEVELOPMENTS 232
13.22.4.1 ACQUISITION 232
13.23 W. L. GORE & ASSOCIATES, INC 233
13.23.1 COMPANY SNAPSHOT 233
13.23.2 PRODUCT PORTFOLIO 233
13.23.3 RECENT DEVELOPMENT 233
14 QUESTIONNAIRE 234
15 RELATED REPORTS 236